Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$274M |
| 2 |
FRLG
Large Cap Growth Index-Linked Exchange Traded Notes due 2028
FRLG
|
+$138M |
| 3 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$69.1M |
| 4 |
Lumentum
LITE
|
+$41.9M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$171M |
| 2 |
Petrobras
PBR
|
+$64.7M |
| 3 |
Vale
VALE
|
+$62.7M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$61.9M |
| 5 |
HDFC Bank
HDB
|
+$57.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Financials | 13.08% |
| 3 | Healthcare | 10.74% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Energy | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Xylem
XYL
$28.5B
| $1.56M | ﹤0.01% |
19,775
+98
| +0.5% | +$7.63K |
|
|
PE
477
DELISTED
PARSLEY ENERGY INC
PE
| $1.55M | ﹤0.01% |
82,222
-852,829
| -91% | -$14.1M |
|
478
Citigroup
C
$231B
| $1.55M | ﹤0.01% |
19,418
+1,021
| +6% | +$75.4K |
|
479
Lantheus
LNTH
$6.61B
| $1.54M | ﹤0.01% |
74,929
+659
| +0.9% | +$13.3K |
|
480
Trane Technologies
TT
$106B
| $1.54M | ﹤0.01% |
11,566
+400
| +4% | +$50.7K |
|
481
iShares Global Financials ETF
IXG
$687M
| $1.53M | ﹤0.01% |
22,305
-405
| -2% | -$26.9K |
|
482
Moog Inc Class A
MOG.A
$12.9B
| $1.48M | ﹤0.01% |
17,342
-5,514
| -24% | -$471K |
|
483
AptarGroup
ATR
$8.69B
| $1.47M | ﹤0.01% |
12,686
-23,452
| -65% | -$2.67M |
|
484
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.51B
| $1.45M | ﹤0.01% |
35,655
+2,429
| +7% | +$95.5K |
|
|
MNTA
485
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.45M | ﹤0.01% |
73,701
| – | – |
|
486
Quanex
NX
$959M
| $1.45M | ﹤0.01% |
84,989
-10,925
| -11% | -$206K |
|
|
ALXN
487
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.42M | ﹤0.01% |
13,135
+331
| +3% | +$35.4K |
|
|
CSFL
488
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $1.4M | ﹤0.01% |
56,053
+75
| +0.1% | +$1.88K |
|
489
Ironwood Pharmaceuticals
IRWD
$683M
| $1.39M | ﹤0.01% |
104,280
-113,257
| -52% | -$1.25M |
|
490
Tetra Tech
TTEK
$8.78B
| $1.37M | ﹤0.01% |
79,410
+60
| +0.1% | +$1.04K |
|
491
Berkshire Hathaway Class A
BRK.A
$1.12T
| $1.36M | ﹤0.01% |
4
-1
| -20% | -$326K |
|
492
Weyerhaeuser
WY
$18.6B
| $1.33M | ﹤0.01% |
44,105
-185,422
| -81% | -$5.38M |
|
493
Lockheed Martin
LMT
$133B
| $1.32M | ﹤0.01% |
3,385
-484
| -13% | -$186K |
|
|
EURZ
494
DELISTED
Xtrackers Eurozone Equity ETF
EURZ
| $1.31M | ﹤0.01% |
56,070
-3,941
| -7% | -$89.3K |
|
495
First Solar
FSLR
$25.4B
| $1.3M | ﹤0.01% |
23,275
+22
| +0.1% | +$1.21K |
|
496
Cencora
COR
$61.7B
| $1.3M | ﹤0.01% |
15,302
-22,216
| -59% | -$1.9M |
|
497
Essex Property Trust
ESS
$18.5B
| $1.3M | ﹤0.01% |
4,309
-14,281
| -77% | -$4.51M |
|
498
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.1B
| $1.28M | ﹤0.01% |
+30,509
| New | +$1.22M |
|
|
FFEU
499
DELISTED
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
| $1.28M | ﹤0.01% |
11,764
-21,830
| -65% | -$2.19M |
|
500
CVS Health
CVS
$126B
| $1.23M | ﹤0.01% |
16,537
+1,628
| +11% | +$114K |
|
Similar funds
Ken Fisher's Q4 2019 Portfolio in Review
As of Q4 2019, Ken Fisher held 981 positions worth $99B, up 8.6% from $91.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Fisher's Q4 2019 filing shows 78 new, 256 increased, 457 reduced and 83 closed positions. Its largest new stake was Enterprise Products Partners: 584,777 shares worth $16.5M. The largest sale was TSMC, an estimated $171M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q4 2019 buy was Enterprise Products Partners: 584,777 shares worth $16.5M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2019, an estimated $274M increase.
- Ken Fisher's biggest Q4 2019 reduction was TSMC, cutting an estimated $171M.
- Ken Fisher fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $61.9M.
- Ken Fisher's ten largest holdings make up 28% of its $99B portfolio in Q4 2019.
- Ken Fisher opened 78 new positions and closed 83 in Q4 2019.
- Ken Fisher's portfolio value rose 8.6% quarter-over-quarter to $99B.
Based on Fisher Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.